A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Monotherapy

NCT01871415 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: aleglitazar
DRUG: metformin
DRUG: placebo

Sponsor

Hoffmann-La Roche